XML 44 R32.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Supplemental Financial Information (Details) shares in Thousands, $ in Millions |  | 1 Months Ended | 3 Months Ended | 6 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | ---
Feb. 27, 2015 shares | Apr. 30, 2015 shares | Jun. 30, 2016 USD ($) | Mar. 31, 2016 USD ($) | Jun. 30, 2015 USD ($) shares | Jun. 30, 2016 USD ($) | Jun. 30, 2015 USD ($) | Feb. 17, 2016 | Feb. 16, 2016 | Dec. 31, 2015 USD ($)
Net earnings |  |  |  |  |  |  |  |  |  |
Earnings from continuing operations allocated to common shares |  |  | $ 597 |  | $ 783 | $ 652 | $ 1,300 |  |  |
Net earnings allocated to common shares |  |  | 612 |  | 780 | 927 | 3,100 |  |  |
Gain on sale of Mylan shares |  |  |  |  |  |  | 207 |  |  |
Proceeds from the sale of Mylan shares |  |  |  |  |  |  | 2,290 |  |  |
Post-employment Obligations and Other Long-term Liabilities: |  |  |  |  |  |  |  |  |  |
Noncash impact of tax benefits from resolution of prior year tax positions |  |  |  |  |  | 410 |  |  |  |
Non-cash impact of tax expense associated with the gain on the sale of businesses |  |  |  |  |  |  | $ 1,100 |  |  |
Investments |  |  |  |  |  |  |  |  |  |
Investments |  |  | $ 3,339 |  |  | 3,339 |  |  |  | $ 4,041
Currency exchange rates |  |  |  |  |  |  |  |  |  |
Foreign currency loss on remeasurement |  |  |  |  |  | 477 |  |  |  |
Mylan |  |  |  |  |  |  |  |  |  |
Net earnings |  |  |  |  |  |  |  |  |  |
Gain on sale of Mylan shares |  |  |  |  | 207 |  |  |  |  |
Number of shares in investment sold | shares |  | 40,250 |  |  |  |  |  |  |  |
Proceeds from the sale of Mylan shares |  |  |  |  | $ 2,290 |  |  |  |  |
Investments |  |  |  |  |  |  |  |  |  |
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc | shares |  | 110,000 |  |  |  |  |  |  |  |
Mylan NV |  |  |  |  |  |  |  |  |  |
Net earnings |  |  |  |  |  |  |  |  |  |
Remaining ownership interest ( as percentage) |  | 14.00% |  |  | 14.00% |  | 14.00% |  |  |
Venezuela |  |  |  |  |  |  |  |  |  |
Post-employment Obligations and Other Long-term Liabilities: |  |  |  |  |  |  |  |  |  |
Cash impact from foreign currency loss |  |  |  |  |  | $ 410 |  |  |  |
Investments |  |  |  |  |  |  |  |  |  |
Abbott's total net assets from Venezuelan operations (as a percent) |  |  | 0.10% |  |  | 0.10% |  |  |  |
Currency exchange rates |  |  |  |  |  |  |  |  |  |
Foreign currency loss on remeasurement |  |  |  | $ 477 |  | $ 477 |  |  |  |
Venezuelan bolivars |  |  |  |  |  |  |  |  |  |
Currency exchange rates |  |  |  |  |  |  |  |  |  |
Official rate to U.S. dollar |  |  |  |  |  |  |  |  |  | 6.3
CENCOEX |  |  |  |  |  |  |  |  |  |
Currency exchange rates |  |  |  |  |  |  |  |  |  |
Official rate to U.S. dollar |  |  |  |  |  |  |  |  |  | 6.3
SICAD |  |  |  |  |  |  |  |  |  |
Currency exchange rates |  |  |  |  |  |  |  |  |  |
Official rate to U.S. dollar |  |  |  |  |  |  |  |  |  | 13.5
SIMADI |  |  |  |  |  |  |  |  |  |
Currency exchange rates |  |  |  |  |  |  |  |  |  |
Official rate to U.S. dollar |  |  |  |  |  |  |  |  |  | 200
DIPRO |  |  |  |  |  |  |  |  |  |
Currency exchange rates |  |  |  |  |  |  |  |  |  |
Official rate to U.S. dollar |  |  |  |  |  |  |  | 10 | 6.3 |
DICOM |  |  |  |  |  |  |  |  |  |
Currency exchange rates |  |  |  |  |  |  |  |  |  |
Official rate to U.S. dollar |  |  |  | 263 |  |  |  |  |  |
Defined Benefit Plans |  |  |  |  |  |  |  |  |  |
Post-employment Obligations and Other Long-term Liabilities: |  |  |  |  |  |  |  |  |  |
Company contributions |  |  |  |  |  | 524 | $ 547 |  |  |
Medical and Dental Plans |  |  |  |  |  |  |  |  |  |
Post-employment Obligations and Other Long-term Liabilities: |  |  |  |  |  |  |  |  |  |
Company contributions |  |  |  |  |  | 9 | $ 24 |  |  |
Equity securities |  |  |  |  |  |  |  |  |  |
Investments |  |  |  |  |  |  |  |  |  |
Investments |  |  | $ 3,288 |  |  | 3,288 |  |  |  | $ 4,014
Other, |  |  |  |  |  |  |  |  |  |
Investments |  |  |  |  |  |  |  |  |  |
Investments |  |  | $ 51 |  |  | 51 |  |  |  | $ 27
Developed markets branded generics pharmaceuticals business |  |  |  |  |  |  |  |  |  |
Post-employment Obligations and Other Long-term Liabilities: |  |  |  |  |  |  |  |  |  |
Cash impact of tax benefits from resolution of prior year tax positions |  |  |  |  |  | $ 140 |  |  |  |
Developed markets branded generics pharmaceuticals business | Mylan |  |  |  |  |  |  |  |  |  |
Net earnings |  |  |  |  |  |  |  |  |  |
Gain on sale of Mylan shares |  |  |  |  | $ 207 |  |  |  |  |
Decrease in fair value of contingent consideration |  |  |  |  | 79 |  |  |  |  |
Proceeds from the sale of Mylan shares |  |  |  |  | $ 2,290 |  |  |  |  |
Investments |  |  |  |  |  |  |  |  |  |
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc | shares | 110,000 |  |  |  |  |  |  |  |  |
Developed markets branded generics pharmaceuticals business | Mylan NV |  |  |  |  |  |  |  |  |  |
Net earnings |  |  |  |  |  |  |  |  |  |
Number of shares in investment sold | shares |  |  |  |  | 40,300 |  |  |  |  |
Investments |  |  |  |  |  |  |  |  |  |
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc | shares |  |  |  |  | 110,000 |  |  |  |  |
Percentage of shares held before sale of generics pharmaceuticals business to Mylan Inc |  |  |  |  | 22.00% |  |  |  |  |

X
- Definition Represents the cash impact for foreign currency loss. + References No definition available. + Details
Name: | abt_CashImpactFromForeignCurrencyLoss
Namespace Prefix: | abt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the cash impact of tax benefits resulting from the resolution of tax positions pertaining to prior years. + References No definition available. + Details
Name: | abt_CashImpactOfTaxBenefitsFromResolutionOfPriorYearTaxPositions
Namespace Prefix: | abt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the number of shares of new business to be received by the company from the buyer as the price for sale of a developed markets branded generics pharmaceuticals business. + References No definition available. + Details
Name: | abt_ConsiderationReceivedForSaleOfBusinessInShares
Namespace Prefix: | abt_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of net income (loss) from continuing operations allocated to common shares during the reporting period. + References No definition available. + Details
Name: | abt_IncomeLossFromContinuingOperationsAllocatedToCommonShares
Namespace Prefix: | abt_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the non-cash impact of tax benefits resulting from the resolution of tax positions pertaining to prior years. + References No definition available. + Details
Name: | abt_NoncashImpactOfTaxBenefitsFromResolutionOfPriorYearTaxPositions
Namespace Prefix: | abt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the percentage of ownership held before sale of business to Mylan. + References No definition available. + Details
Name: | abt_PercentageOfOwnershipHeldBeforeSaleOfBusiness
Namespace Prefix: | abt_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the Abbott's total assets from Venezuelan operations. + References No definition available. + Details
Name: | abt_PercentageOfTotalNetAssets
Namespace Prefix: | abt_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | abt_PostemploymentObligationsAndOtherLongTermLiabilitiesAbstract
Namespace Prefix: | abt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents number of shares in investment is sold. + References No definition available. + Details
Name: | abt_SaleOfStockNumberOfSharesSold
Namespace Prefix: | abt_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) in the value of right to a contingent consideration asset. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 4 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase in the fair value of plan assets from contributions made by the employer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b)(3) -URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920 + Details
Name: | us-gaap_DefinedBenefitPlanContributionsByEmployer
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3B -URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 20 -Section 45 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=18498875&loc=d3e38679-109324 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5C -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760 + Details
Name: | us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521 + Details
Name: | us-gaap_ForeignCurrencyExchangeRateTranslation1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30690-110894 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30700-110894 + Details
Name: | us-gaap_ForeignCurrencyTransactionLossBeforeTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.13(h)) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 + Details
Name: | us-gaap_GainLossOnSaleOfEquityInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_LongTermInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_LongTermInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_MultipleForeignCurrencyExchangeRatesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256 + Details
Name: | us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=abt_MylanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=abt_MyLanNVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_VE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CurrencyAxis=currency_VEF
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CurrencyAxis=abt_CENCOEXMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CurrencyAxis=abt_SICDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CurrencyAxis=abt_SIMDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CurrencyAxis=abt_DIPRORateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CurrencyAxis=abt_DICOMRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_PensionPlansDefinedBenefitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DisposalGroupClassificationAxis=abt_DevelopedMarketsBrandedGenericsPharmaceuticalsBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |